MyFinsight
Home
About
Contact
akro: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, AKRO has $1,005,577K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Buy me a coffee
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
1,005,577
1,109,152
Total stockholders' equity
957,637
1,025,819
Total liabilities and stockholders' equity
1,005,577
1,109,152
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$16,709K
Short-term marketable
securities
$561,794K
Cash and cash
equivalents
$176,032K
Right of use asset
$552K
Long-term marketable
securities
$250,490K
Total current assets
$754,535K
Total assets
$1,005,577K
Total liabilities and
stockholders' equity
$1,005,577K
Total stockholders'
equity
$957,637K
Total liabilities
$47,940K
Accumulated deficit
-$1,048,952K
Accumulated other
comprehensive income
$1,826K
Additional paid-in capital
$2,004,755K
Operating lease
liability, noncurrent
$289K
Total current
liabilities
$47,651K
Common stock, 0.0001
par value,...
$8K
Accrued expenses and
other current...
$27,252K
Accounts payable
$20,399K
Buy me a coffee
Akero Therapeutics, Inc. (AKRO)
Akero Therapeutics, Inc. (AKRO)